{"id":"https://openalex.org/W2575950737","doi":"https://doi.org/10.1182/blood.v120.21.558.558","title":"Novel Recurrent Mutations in the Ras-Like GTP-Binding Gene Rit1 in Myeloid Malignancies","display_name":"Novel Recurrent Mutations in the Ras-Like GTP-Binding Gene Rit1 in Myeloid Malignancies","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2575950737","doi":"https://doi.org/10.1182/blood.v120.21.558.558","mag":"2575950737"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.558.558","doi":"https://doi.org/10.1182/blood.v120.21.558.558","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.558.558","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5098604214","display_name":"In\u00e9es G\u00f3omez-Segu\u00edi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ine\u0301es Go\u0301omez-Segui\u0301i","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050620740","display_name":"Hideki Makishima","orcid":"https://orcid.org/0000-0001-5983-8578","observed_orcids":["https://orcid.org/0000-0001-5983-8578"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hideki Makishima","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088353355","display_name":"Andr\u00e9s Jerez","orcid":"https://orcid.org/0000-0002-2079-6638","observed_orcids":["https://orcid.org/0000-0002-2079-6638"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andres Jerez","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031014013","display_name":"Kenichi Yoshida","orcid":"https://orcid.org/0000-0003-4612-2778","observed_orcids":["https://orcid.org/0000-0003-4612-2778"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kenichi Yoshida","raw_affiliation_strings":["Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022299669","display_name":"Bartlomiej P. Przychodzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bartlomiej P Przychodzen","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088167618","display_name":"Satoru Miyano","orcid":"https://orcid.org/0000-0002-1753-6616","observed_orcids":["https://orcid.org/0000-0002-1753-6616"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Satoru Miyano","raw_affiliation_strings":["Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030942209","display_name":"Yuichi Shiraishi","orcid":"https://orcid.org/0000-0001-6144-5845","observed_orcids":["https://orcid.org/0000-0001-6144-5845","https://orcid.org/0009-0004-2375-2827"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuichi Shiraishi","raw_affiliation_strings":["Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005451978","display_name":"Holleh D. Husseinzadeh","orcid":"https://orcid.org/0000-0002-6205-8756","observed_orcids":["https://orcid.org/0000-0002-6205-8756"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holleh D Husseinzadeh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Edward P Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edward P Evans","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026679136","display_name":"Kathryn M Guinta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kathryn M Guinta","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002411804","display_name":"Naoko Hosono","orcid":"https://orcid.org/0000-0002-6336-3250","observed_orcids":["https://orcid.org/0000-0002-6336-3250"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Naoko Hosono","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078527108","display_name":"Michael A. McDevitt","orcid":"https://orcid.org/0000-0003-0031-5881","observed_orcids":["https://orcid.org/0000-0003-0031-5881"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A McDevitt","raw_affiliation_strings":["Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA,","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076437910","display_name":"Alison R. Moliterno","orcid":"https://orcid.org/0000-0002-8673-4317","observed_orcids":["https://orcid.org/0000-0002-8673-4317"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison R. Moliterno","raw_affiliation_strings":["Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA,","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042588749","display_name":"Seishi Ogawa","orcid":"https://orcid.org/0000-0002-7778-5374","observed_orcids":["https://orcid.org/0000-0002-7778-5374"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seishi Ogawa","raw_affiliation_strings":["Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslaw P. Maciejewski","raw_affiliation_strings":["Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA,","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5002411804","https://openalex.org/A5022299669","https://openalex.org/A5026679136","https://openalex.org/A5030942209","https://openalex.org/A5031014013","https://openalex.org/A5088167618","https://openalex.org/A5088353355","https://openalex.org/A5098604214"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I74801974"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.36673421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"120","issue":"21","first_page":"558","last_page":"558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rit1","display_name":"RIT1","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ras-like-gtpases","display_name":"Ras-related GTPases","score":0.7889999747276306},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.8560000061988831},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9259999990463257},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9700000286102295},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.7149999737739563},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7889999747276306},{"id":"https://openalex.org/keywords/p38-mapk-signaling","display_name":"p38 MAPK signaling","score":0.8090000152587891},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.9419999718666077}],"concepts":[{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7706795930862427},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6854816675186157},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.65213543176651},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6277444362640381},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5178983211517334},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.49733975529670715},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4642888307571411},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.44132450222969055},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4141656160354614},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3914843201637268},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.30237239599227905},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1792934238910675},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.07900750637054443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.558.558","doi":"https://doi.org/10.1182/blood.v120.21.558.558","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.558.558","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6800000071525574,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417001617","https://openalex.org/W3096498096","https://openalex.org/W2160123981","https://openalex.org/W3159626057","https://openalex.org/W1993012620","https://openalex.org/W976503602","https://openalex.org/W1585617332","https://openalex.org/W1992900193","https://openalex.org/W2558122873","https://openalex.org/W1981125188"],"abstract_inverted_index":{"Abstract":[0,1],"558":[2],"In":[3,66,401,600,619],"addition":[4],"to":[5,97,206,301,537,650,660],"chromosomal":[6],"and":[7,31,59,75,110,125,130,134,162,196,263,284,306,359,370,395,434,512,522,533,543,573],"epigenetic":[8],"abnormalities,":[9],"somatic":[10,20,141,170,242,265,621],"mutations":[11,21,51,70,127,143,174,223,267,275,329,344,382,559,624],"constitute":[12,561],"key":[13],"pathogenic":[14],"lesions":[15,627],"in":[16,52,57,62,79,103,128,144,154,175,192,204,214,230,268,278,281,324,330,347,373,385,421,463,520,523,546,601,629,638,664,673],"myeloid":[17,67,81,231,258,634],"neoplasms.":[18],"Individual":[19],"or":[22],"various":[23,47,257],"combinations":[24],"may":[25,451,560],"be":[26,452,661,671],"both":[27,173],"valuable":[28],"prognostic":[29],"markers":[30],"targets":[32],"for":[33,389],"new":[34],"rational":[35],"therapies.":[36],"Among":[37,313],"them,":[38],"RAS":[39,69,119],"family":[40],"genes":[41],"are":[42,76,625],"ubiquitous":[43],"oncogenes":[44],"associated":[45],"with":[46,157,256,366,392,414,525,539,597,612,666],"cancers.":[48],"Recurrent":[49],"canonical":[50],"the":[53,118,145,169,193,282,289,302,314,374,398,402,415,428,432,441,468,473,488,505,576,592,630,639,642],"nucleotide":[54],"binding":[55],"domains":[56],"NRAS":[58],"KRAS":[60,133],"result":[61],"constitutively":[63],"activated":[64],"proteins.":[65],"neoplasms,":[68],"convey":[71],"a":[72,186,251,325,418,485,496,513,562,605],"poor":[73],"prognosis":[74],"often":[77],"found":[78,213,346,480,672],"acute":[80],"leukemia":[82,101,160],"(AML),":[83],"myelodysplastic":[84],"syndromes":[85],"(MDS)":[86],"and,":[87],"rarely,":[88],"myeloproliferative":[89],"neoplasms":[90],"(MPN).":[91],"We":[92,113,167,233,479,554],"applied":[93],"whole":[94],"exome":[95],"sequencing":[96,262],"paired":[98],"germline":[99],"vs.":[100],"samples":[102,436],"65":[104],"cases":[105,387,403,482,494],"of":[106,122,132,148,172,188,216,224,238,253,293,328,333,337,355,378,397,404,411,417,423,427,431,443,453,470,472,498,579,594,607,633,641,646,652,676],"MDS,":[107,362],"36":[108],"MDS/MPN":[109],"32":[111],"sAML.":[112],"focused":[114,235],"our":[115],"study":[116],"on":[117,240],"protein":[120],"superfamily":[121],"small":[123],"GTPases":[124],"identified":[126,140],"3%":[129],"6%":[131],"NRAS,":[135],"respectively.":[136,166],"Most":[137],"significantly,":[138],"we":[139,248,406,465,582],"recurrent":[142,622],"F82":[146],"residue":[147],"Ras-like":[149,654],"without":[150],"CAAX1":[151],"(RIT1)":[152],"gene":[153,184,209,226,458],"2":[155],"patients":[156,255,507,524,538,665],"chronic":[158],"myelomonocytic":[159],"(CMML)":[161],"secondary":[163],"AML":[164],"(sAML),":[165],"confirmed":[168],"nature":[171],"sorted":[176],"CD3+":[177],"cells":[178,596],"from":[179],"each":[180],"patient":[181],"(pt).":[182],"RIT1":[183,208,266,381,438,450,474,489,518,542,558,598,623,647],"encodes":[185],"member":[187],"Ras-related":[189],"GTPases,":[190],"involved":[191,628],"p38":[194],"MAPK":[195],"AKT":[197,567,571,585],"signaling":[198],"pathway":[199],"that":[200,449,556],"mediates":[201],"cellular":[202],"survival":[203],"response":[205],"stress.":[207],"amplification":[210,221,527,545],"has":[211],"been":[212,228,461],"26%":[215],"hepatocellular":[217],"carcinoma.":[218],"However,":[219],"neither":[220],"nor":[222],"this":[225,236,241,294,331,653],"have":[227,460],"reported":[229],"malignancies.":[232],"thus":[234],"line":[237],"experimentation":[239],"mutation.":[243,599],"To":[244],"establish":[245],"clinical":[246],"associations":[247],"further":[249],"studied":[250,467],"cohort":[252],"322":[254],"malignancies":[259],"by":[260,477,484],"Sanger":[261],"detected":[264],"an":[269,296,408],"additional":[270],"6":[271],"(2%)":[272],"cases.":[273],"All":[274],"were":[276,345,383],"located":[277],"exon":[279],"5,":[280],"81":[283],"82":[285],"residues,":[286],"which":[287,307],"encode":[288],"switch":[290],"II":[291],"domain":[292],"protein,":[295],"effector":[297],"region":[298,490],"very":[299],"close":[300],"GTP-binding":[303],"site":[304],"G3,":[305],"is":[308,447],"highly":[309],"conserved":[310],"among":[311],"species.":[312],"8":[315],"mutant":[316,399,580],"cases,":[317],"5":[318],"(63%)":[319],"pts":[320,334],"had":[321,495,502,508],"CMML,":[322,339,499,667],"resulting":[323],"higher":[326],"frequency":[327,410],"subcohort":[332],"(5":[335],"out":[336,354,377],"57":[338],"9%).":[340],"The":[341],"other":[342,674],"3":[343],"one":[348,363,371,390],"primary":[349,595],"(p)AML":[350],"(M5b":[351],"subtype)":[352],"(1":[353],"58":[356],"pAML,":[357],"2%)":[358],"two":[360],"high-grade":[361],"refractory":[364],"anemia":[365],"excess":[367],"blasts":[368],"(RAEB)-2":[369],"sAML(RAEB-T":[372],"FAB-classification)":[375],"(2":[376],"80,":[379],"2.5%).":[380],"heterozygous":[384,419],"all":[386],"except":[388],"case":[391],"trisomy":[393],"1":[394],"duplication":[396],"allele.":[400],"WES,":[405],"estimated":[407],"allelic":[409],"\u223c35%,":[412],"consistent":[413],"presence":[416,469],"mutation":[420,439],"\u223c70%":[422],"sample":[424],"cells.":[425],"Because":[426,566],"large":[429],"size":[430],"clone":[433],"serial":[435],"showing":[437],"since":[440],"time":[442],"initial":[444],"diagnosis,":[445],"it":[446],"likely":[448],"ancestral":[454],"origin.":[455],"As":[456],"RAS-family":[457],"amplifications":[459,471,645],"described":[462],"cancer,":[464],"also":[466,648,669],"locus":[475],"(1q22)":[476],"SNP-A.":[478],"10":[481],"characterized":[483],"gain":[486],"involving":[487],"(1q21.1-q44):":[491],"4":[492,500],"(40%)":[493,501],"diagnosis":[497],"myelofibrosis,":[503],"whereas":[504],"remaining":[506],"MDS":[509],"(one":[510],"RAEB-1":[511],"RA).":[514],"Quantitative":[515],"RT-PCR":[516],"showed":[517],"overexpression":[519,651],"mutants":[521],"1q":[526,547],"(median":[528,548],"normalized":[529,549],"relative":[530,550],"ratio":[531,551],"0,51":[532],"0,40,":[534],"respectively)":[535],"compared":[536],"wild":[540],"type":[541],"no":[544],"0,15;":[552],"P=.039).":[553],"theorized":[555],"activating":[557],"suitable":[563],"therapeutic":[564],"target.":[565],"inhibitors":[568],"can":[569,589,670],"block":[570],"phosphorylation":[572],"therefore":[574],"reverse":[575],"antiapoptotic":[577],"effect":[578],"RIT1,":[581],"tested":[583],"whether":[584],"inhibitor":[586],"V":[587],"(Triciribine)":[588],"selectively":[590],"abrogate":[591],"growth":[593],"vitro":[602],"suspension":[603],"cultures,":[604],"65%":[606],"reduction":[608],"proliferation":[609],"was":[610],"observed":[611],"significant":[613],"effects":[614],"even":[615],"at":[616],"0.1\u03bcM":[617],"concentrations.":[618],"sum,":[620],"novel":[626],"molecular":[631],"pathogenesis":[632],"cancers,":[635],"presumably":[636],"early":[637],"development":[640],"disease.":[643],"Moreover,":[644],"lead":[649],"GTP-ase.":[655],"Specifically,":[656],"these":[657],"abnormalities":[658],"appear":[659],"more":[662],"frequent":[663],"but":[668],"types":[675],"MDS.":[677],"Disclosures:":[678],"Makishima:":[679],"Scott":[680],"Hamilton":[681],"CARES":[682],"Initiative:":[683],"Research":[684,687,693],"Funding.":[685,694],"Maciejewski:NIH:":[686],"Funding;":[688],"Aplastic":[689],"Anemia&MDS":[690],"International":[691],"Foundation:":[692]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2017-01-26T00:00:00"}